Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer

Genes Chromosomes and Cancer

Volumn 48, Issue 11, 2009, Pages 1002-1017

  Camps, Jordi ^a   Quang, Tri Nguyen ^a   Padilla Nash, Hesed M ^a   Knutsen, Turid ^a   McNeil, Nicole E ^a   Wangsa, Danny ^a   Hummon, Amanda B ^a   Grade, Marian ^a,b   Ried, Thomas ^a   Difilippantonio, Michael J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MYC PROTEIN; PROTEIN FAM 84 B; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; GENE AMPLIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENOMICS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SPECTRAL KARYOTYPING; TUMOR GENE;

CELL LINE, TUMOR; CHROMOSOME BREAKPOINTS; CHROMOSOMES, HUMAN, PAIR 8; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, VIRUS; SPECTRAL KARYOTYPING; TRANSCRIPTION, GENETIC;

EID: 70349317146     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20699     Document Type: Article

References (42)

1. Abdel-Rahman WM, Katsura K, Rens W, Gorman PA, Sheer D, Bicknell D, Bodmer WF, Arends MJ, Wyllie AH, Edwards PA. 2001. Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc Natl Acad Sci USA 98:2538-2543. (Pubitemid 32209517)
2. Albertson DG. 2006. Gene amplification in cancer. Trends Genet 22:447-455.
3. Alsop AE, Taylor K, Zhang J, Gabra H, Paige AJ, Edwards PA. 2008. Homozygous deletions may be markers of nearby heterozygous mutations: The complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX. Genes Chromosomes Cancer 47:437-447.
4. Arribas R, Risques RA, Gonzalez-Garcia I, Masramon L, Aiza G, Ribas M, Capella G, Peinado MA. 1999. Tracking recurrent quantitative genomic alterations in colorectal cancer: Allelic losses in chromosome 4 correlate with tumor aggressiveness. Lab Invest 79:111-122. (Pubitemid 29110642)
5. Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Lindstrom C, Tornqvist A, Frederiksen H, Andren-Sandberg A, Mitelman F, Heim S. 1993. Cytogenetic analysis of 52 colorectal carcinomas - Non-random aberration pattern and correlation with pathologic parameters. Int J Cancer 55:422-428. (Pubitemid 23300593)
6. Bea S, Salaverria I, Armengol L, Pinyol M, Fernandez V, Hartmann EM, Jares P, Amador V, Hernandez L, Navarro A, Ott G, Rosenwald A, Estivill X, Campo E. 2009. Uniparental disomies, homozygous deletions, amplifications and target genes in mantle cell lymphoma revealed by integrative high-resolution whole genome profiling. Blood 113:3059-3069.
7. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501. (Pubitemid 28538613)
8. Camps J, Armengol G, del Rey J, Lozano JJ, Vauhkonen H, Prat E, Egozcue J, Sumoy L, Knuutila S, Miro R. 2006. Genomewide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 27:419-428. (Pubitemid 43372871)
9. Camps J, Grade M, Nguyen QT, Hormann P, Becker S, Hummon AB, Rodriguez V, Chandrasekharappa S, Chen Y, Difilippantonio MJ, Becker H, Ghadimi BM, Ried T. 2008. Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res 68:1284-1295. (Pubitemid 351346834)
10. Camps J, Morales C, Prat E, Ribas M, Capella G, Egozcue J, Peinado MA, Miro R. 2004. Genetic evolution in colon cancer KM12 cells and metastatic derivates. Int J Cancer 110:869-874. (Pubitemid 38758513)
11. Clark PE, Cookson MS. 2008. The von Hippel-Lindau gene: Turning discovery into therapy. Cancer 113:1768-1778.
12. Douglas EJ, Fiegler H, Rowan A, Halford S, Bicknell DC, Bodmer W, Tomlinson IP, Carter NP. 2004. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 64:4817-4825. (Pubitemid 38924525)
13. Eshleman JR, Casey G, Kochera ME, Sedwick WD, Swinler SE, Veigl ML, Willson JK, Schwartz S, Markowitz SD. 1998. Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53. Oncogene 17:719-725. (Pubitemid 28412492)
14. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
15. Fix A, Lucchesi C, Ribeiro A, Lequin D, Pierron G, Schleiermacher G, Delattre O, Janoueix-Lerosey I. 2008. Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identifi- cation of overexpressed genes. Genes Chromosomes Cancer 47:819-834.
16. Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, Auer G, Ried T. 2000. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer 27:183-190. (Pubitemid 30030317)
17. Gisselsson D, Pettersson L, Hoglund M, Heidenblad M, Gorunova L, Wiegant J, Mertens F, Dal Cin P, Mitelman F, Mandahl N. 2000. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 97:5357-5362. (Pubitemid 30313723)
18. Grade M, Ghadimi BM, Varma S, Simon R, Wangsa D, Barenboim- Stapleton L, Liersch T, Becker H, Ried T, Difilippantonio MJ. 2006. Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/ beta-catenin signaling pathway in human rectal carcinomas. Cancer Res 66:267-282. (Pubitemid 43166033)
19. Guan XY, Meltzer PS, Dalton WS, Trent JM. 1994. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet 8:155-161.
20. Huang XP, Rong TH, Wang JY, Tang YQ, Li BJ, Xu DR, Zhao MQ, Zhang LJ, Fang Y, Su XD, Liang QW. 2006. Negative implication of C-MYC as an amplification target in esophageal cancer. Cancer Genet Cytogenet 165:20-24. (Pubitemid 43254648)
21. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. 2008. Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
22. Kasugai Y, Tagawa H, Kameoka Y, Morishima Y, Nakamura S, Seto M. 2005. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma. Clin Cancer Res 11:8265-8272. (Pubitemid 41746936)
23. Kendall J, Liu Q, Bakleh A, Krasnitz A, Nguyen KC, Lakshmi B, Gerald WL, Powers S, Mu D. 2007. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci USA 104:16663-16668. (Pubitemid 350211073)
24. Kleivi K, Teixeira MR, Eknaes M, Diep CB, Jakobsen KS, Hamelin R, Lothe RA. 2004. Genome signatures of colon carcinoma cell lines. Cancer Genet Cytogenet 155:119-131. (Pubitemid 39574921)
25. Knösel T, Schluns K, Stein U, Schwabe H, Schlag PM, Dietel M, Petersen I. 2004. Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer. Neoplasia 6:23-28. (Pubitemid 38391946)
26. Li MM, Nimmakayalu MA, Mercer D, Andersson HC, Emanuel BS. 2008. Characterization of a cryptic 3.3 Mb deletion in a patient with a "balanced t(15;22) translocation" using high density oligo array CGH and gene expression arrays. Am J Med Genet A 146:368-375.
27. Martin ES, Tonon G, Sinha R, Xiao Y, Feng B, Kimmelman AC, Protopopov A, Ivanova E, Brennan C, Montgomery K, Kucherlapati R, Bailey G, Redston M, Chin L, DePinho RA. 2007. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. Cancer Res 67:10736-10743. (Pubitemid 350145900)
28. Mitelman F, Johansson B, Mertens F. 2004. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 36:331-334. (Pubitemid 38437252)
29. Miyoshi M, Okajima T, Matsuda T, Fukuda MN, Nadano D. 2007. Bystin in human cancer cells: Intracellular localization and function in ribosome biogenesis. Biochem J 404:373-381. (Pubitemid 46953911)
30. Monni O, Barlund M, Mousses S, Kononen J, Sauter G, Heiskanen M, Paavola P, Avela K, Chen Y, Bittner ML, Kallioniemi A. 2001. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA 98:5711-5716. (Pubitemid 32435707)
31. Myllykangas S, Knuutila S. 2006. Manifestation, mechanisms and mysteries of gene amplifications. Cancer Lett 232:79-89. (Pubitemid 43053935)
32. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515-527. (Pubitemid 44854747)
33. Olshen AB, Venkatraman ES, Lucito R, Wigler M. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5:557-572. (Pubitemid 41180205)
34. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL, Brown PO. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99:12963-12968.
35. Prat A, Baselga J. 2008. The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with coexpression of HER2. Nat Clin Pract Oncol 5:531-542.
36. Qi C, Zhu YT, Hu L, Zhu YJ. 2009. Identification of Fat4 as a candidate tumor suppressor gene in breast cancers. Int J Cancer 124:793-798.
37. Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K, du Manoir S, Auer G. 1996. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15:234-245.
38. Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, Lababidi S, Scudiero DA, Weinstein JN, Kirsch IR. 2003. Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res 63:8634-8647. (Pubitemid 38064038)
39. Saburi S, Hester I, Fischer E, Pontoglio M, Eremina V, Gessler M, Quaggin SE, Harrison R, Mount R, McNeill H. 2008. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease. Nat Genet 40:1010-1015.
40. Squire JA, Thorner PS, Weitzman S, Maggi JD, Dirks P, Doyle J, Hale M, Godbout R. 1995. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene 10:1417-1422.
41. Tsukamoto Y, Uchida T, Karnan S, Noguchi T, Nguyen LT, Tanigawa M, Takeuchi I, Matsuura K, Hijiya N, Nakada C, Kishida T, Kawahara K, Ito H, Murakami K, Fujioka T, Seto M, Moriyama M. 2008. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol 216:471-482.
42. Yoshimoto M, Ludkovski O, Bayani J, Graham C, Zielenska M, Squire JA. 2007. Microdeletion and concurrent translocation associated with a complex TMPRSS2:ERG prostate cancer gene fusion. Genes Chromosomes Cancer 46:861-863.